Citi Assumes Acceleron Pharma (XLRN) at Buy

May 24, 2019 5:15 AM EDT
Get Alerts XLRN Hot Sheet
Price: $178.75 --0%

Rating Summary:
    11 Buy, 11 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 10 | Down: 31 | New: 13
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Citi analyst Yigal Nochomovitz assumes coverage on Acceleron Pharma (NASDAQ: XLRN) with a Buy rating and a price target of $66.00 (from $63.00).

For an analyst ratings summary and ratings history on Acceleron Pharma click here. For more ratings news on Acceleron Pharma click here.

Shares of Acceleron Pharma closed at $41.57 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

New Coverage

Related Entities